Streetbeat News

Price Targets

ABBV

BMO Capital analyst Evan David Seigerman maintains an Outperform rating on AbbVie (NYSE:ABBV) and raises the price target from $187 to $195.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:57 pm

ACAD

Oppenheimer analyst Jay Olson has reiterated a 'Perform' rating on ACADIA Pharmaceuticals (ACAD) and maintained a $25 price target.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:53 pm

TEVA

Barclays analyst Balaji Prasad maintains an Overweight rating on Teva Pharmaceutical Industries (TEVA) and raises the price target from $15 to $17.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:53 pm

WT

Oppenheimer analyst Chris Kotowski maintains an Outperform rating on WisdomTree (NYSE:WT) and raises the price target from $11 to $12.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:51 pm

ROP

Barclays analyst Julian Mitchell has maintained an Overweight rating on Roper Technologies (NASDAQ:ROP) and increased the price target from $580 to $596.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:45 pm

EXPE

Oppenheimer analyst Jed Kelly has reiterated an Outperform rating on Expedia Group (NASDAQ:EXPE), maintaining a price target of $175.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:45 pm

CHD

Oppenheimer analyst Rupesh Parikh maintains an Outperform rating on Church & Dwight Co (NYSE:CHD) and raises the price target from $107 to $110.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:43 pm

PSX

Barclays analyst Theresa Chen maintains an Equal-Weight rating on Phillips 66 (NYSE:PSX) and raises the price target from $132 to $139.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:42 pm

CBOE

Oppenheimer analyst Owen Lau maintains an Outperform rating on Cboe Global Markets and raises the price target from $201 to $206.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:41 pm

NVDA

NVIDIA shares are trading higher following an upgrade by Goldman Sachs, which raised its price target on the stock from $625 to $800 and added it to the Conviction List.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:40 pm